These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17964670)

  • 1. Inhibition of human parainfluenza virus type 3 infection by novel small molecules.
    Mao H; Thakur CS; Chattopadhyay S; Silverman RH; Gudkov A; Banerjee AK
    Antiviral Res; 2008 Feb; 77(2):83-94. PubMed ID: 17964670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Human Parainfluenza Virus Infection by Preactivating the Cell Entry Mechanism.
    Bottom-Tanzer SF; Rybkina K; Bell JN; Alabi CA; Mathieu C; Lu M; Biswas S; Vasquez M; Porotto M; Melero JA; Más V; Moscona A
    mBio; 2019 Feb; 10(1):. PubMed ID: 30782664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminally truncated C protein, CNDelta25, of human parainfluenza virus type 3 is a potent inhibitor of viral replication.
    Mao H; Chattopadhyay S; Banerjee AK
    Virology; 2009 Nov; 394(1):143-8. PubMed ID: 19747707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon action against human parainfluenza virus type 3: involvement of a novel antiviral pathway in the inhibition of transcription.
    Choudhary S; Gao J; Leaman DW; De BP
    J Virol; 2001 May; 75(10):4823-31. PubMed ID: 11312354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesiculopolins, a New Class of Anti-Vesiculoviral Compounds, Inhibit Transcription Initiation of Vesiculoviruses.
    Ogino M; Fedorov Y; Adams DJ; Okada K; Ito N; Sugiyama M; Ogino T
    Viruses; 2019 Sep; 11(9):. PubMed ID: 31540123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inclusion Body Fusion of Human Parainfluenza Virus Type 3 Regulated by Acetylated α-Tubulin Enhances Viral Replication.
    Zhang S; Jiang Y; Cheng Q; Zhong Y; Qin Y; Chen M
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A recombinant, infectious human parainfluenza virus type 3 expressing the enhanced green fluorescent protein for use in high-throughput antiviral assays.
    Roth JP; Li JK; Smee DF; Morrey JD; Barnard DL
    Antiviral Res; 2009 Apr; 82(1):12-21. PubMed ID: 19189850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.
    Schmidt AC; McAuliffe JM; Murphy BR; Collins PL
    J Virol; 2001 May; 75(10):4594-603. PubMed ID: 11312329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation.
    Zhang C; Zhang K; Zang G; Chen T; Lu N; Wang S; Zhang G
    Biomed Res Int; 2021; 2021():1807293. PubMed ID: 34409100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective antibodies against human parainfluenza virus type 3 infection.
    Boonyaratanakornkit J; Singh S; Weidle C; Rodarte J; Bakthavatsalam R; Perkins J; Stewart-Jones GBE; Kwong PD; McGuire AT; Pancera M; Taylor JJ
    MAbs; 2021; 13(1):1912884. PubMed ID: 33876699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway.
    Gao J; De BP; Banerjee AK
    J Virol; 1999 Feb; 73(2):1411-8. PubMed ID: 9882346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sumoylation of Human Parainfluenza Virus Type 3 Phosphoprotein Correlates with A Reduction in Viral Replication.
    Cheng Q; Huai W; Wu X; Chen M
    Virol Sin; 2021 Jun; 36(3):438-448. PubMed ID: 33197004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of NH(2)- and COOH-terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication.
    De BP; Hoffman MA; Choudhary S; Huntley CC; Banerjee AK
    J Virol; 2000 Jul; 74(13):5886-95. PubMed ID: 10846069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of the D domain of the human parainfluenza virus type 3 (HPIV3) PD protein results in decreased viral RNA synthesis and beta interferon (IFN-β) expression.
    Roth JP; Li JK; Morrey JD; Barnard DL; Vollmer AH
    Virus Genes; 2013 Aug; 47(1):10-9. PubMed ID: 23686695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Guided Improvement of a Dual HPIV3/RSV Fusion Inhibitor.
    Outlaw VK; Lemke JT; Zhu Y; Gellman SH; Porotto M; Moscona A
    J Am Chem Soc; 2020 Feb; 142(5):2140-2144. PubMed ID: 31951396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites.
    Porotto M; Murrell M; Greengard O; Lawrence MC; McKimm-Breschkin JL; Moscona A
    J Virol; 2004 Dec; 78(24):13911-9. PubMed ID: 15564499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
    Ohol YM; Wang Z; Kemble G; Duke G
    PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.
    Liang B; Ngwuta JO; Herbert R; Swerczek J; Dorward DW; Amaro-Carambot E; Mackow N; Kabatova B; Lingemann M; Surman S; Yang L; Chen M; Moin SM; Kumar A; McLellan JS; Kwong PD; Graham BS; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2016 Nov; 90(21):10022-10038. PubMed ID: 27581977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N
    Zhang S; Cheng Q; Luo C; Yin L; Qin Y; Chen M
    Virology; 2018 May; 518():64-76. PubMed ID: 29455063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of human parainfluenza 3 clinical isolates to ribavirin, favipiravir and zanamivir.
    Smielewska A; Emmott E; Goodfellow I; Jalal H
    J Clin Virol; 2018 May; 102():19-26. PubMed ID: 29477132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.